2016 Global Life Science Funding & Lab Budget Outlook

2016 Life Science Global Funding & Lab Budget Outlook

July 2015

gene2drug.com Life Science Industry Market Research

Life Science Industry Market Research

gene2drug.com

About this Report

•Economic landscape

•Report scope

•Sponsorship opportunities and contact info

2


gene2drug.com

About BioInformatics LLC

3

A full-service market research firm since 1994:

• Published & syndicated reports

• Consulting & strategy development

• Expert interviews

• Focus groups

• RateMyProduct™

• Strategic Directions International (Now a part of BioInformatics)

• Interactive Market Intelligence (New in 2015)


gene2drug.com


Conducting market research exclusively on scientific markets:

• Lab products

• Analytical instrumentation

• Biotechnology research & bioprocessing

• Drug discovery & development

• Molecular diagnostics

4


gene2drug.com


5

Project team includes scientists, statisticians and business analysts

Instant access to a 75,000+ expert scientific panel

Conduct market research for major suppliers in the industry


gene2drug.com

Report Authors & Lead Analysts

Robin Rothrock, Ph.D.

Director of Publications, BioInformatics LLC

Glenn Cudiamat

VP of Research Services, SDi

6


gene2drug.com 7

Overview of the Economic Landscape


gene2drug.com 8


gene2drug.com

United States

Obama administration outlines ~5% budget increase for R&D FY2016

Flat to declining pharma/biotech R&D budgets

USD headwinds

M&A to stay hot

Venture capital funding new technologies

2016 Elections

9


gene2drug.com

Europe

Continued fiscal austerity policies

Public support for scientific research remains high

Debt crises, weakened Euro

Recent headlines add strain

GDP and cross-border collaboration

10


gene2drug.com

Asia

13th Five-Year Plan (2016-2020) blueprint has not yet been revealed

In 2011-2015, China poured unprecedented investment into biotech

As growth has decelerated in China, healthcare investment priorities may shift but not likely

Japan underperforming but significant scientific R&D infusion

India surpasses China in growth

11


gene2drug.com

Stuck in ‘The New Normal’

Added currency headwinds & EU debt crises linger

Challenging research funding due to bottom-line pressures

Signs of momentum in Asia

12


gene2drug.com 13

Report Scope


gene2drug.com

Objectives

Understand current sources of funding

Compare and contrast FY2015 (actual), and FY2016 (projected) average lab budgets

Estimate scientists’ budget for purchases and anticipated purchases in instrumentation and consumables

Take the pulse of the life science community regarding funding and the future of life science research

14


gene2drug.com

Framework

Secondary research

An extensive review of relevant research councils, funding agencies and private funding sources

United States, Europe and Asia*

*Asia secondary research is new addition to the Outlook report

Primary research

Quantitative survey administered to life scientists in the United States, Europe and Asia

Have budget authority

Sample size ≅ 1,000

75% academic/gov’t and 25% life science industry

15


gene2drug.com

Questionnaire

Funding & Budgets

• Current sources of funding

• Average lab budgets (2015 and 2016)

• Average lab budgets for instrumentation

• Average lab budgets for consumables

• Percent budget allocation for overhead and salaries

• Laboratory headcount

Techniques

• Current usage

• Explore adoption of new products/techniques in the next 12 months

• Purchase of instrumentation (actual in 2015 and expected in 2016)

• Identify new and emerging technologies

16


gene2drug.com

Customer Sentiment

17

Will my project be

funded next year?


gene2drug.com

Product Categories

Instrumentation for…

• Cell-based analysis (flow cytometers, high content analyzers, all microscopes, high throughput screening and analysis systems, etc.)

• Genome analysis (thermal cyclers, real-time PCR instrumentation, microarray instrumentation, NGS, capillary electrophoresis, etc.)

• Protein analysis (chromatography, electrophoresis, mass spectrometry, label-free detection, calorimetry, NMR, CD, etc.)

Consumables

• Cell-based analysis kits and reagents (cell culture media and reagents, antibodies, cell biology kits, etc.)

• Genome analysis kits and reagents (enzymes, kits, ladders, nucleic acid purification and separation products, oligonucleotides [primers, RNAi], etc.)

• Protein purification and separation kits and reagents (chromatography media, electrophoresis matrices, protein ladders, etc.)

• Animal models portion (New)

• General laboratory18


gene2drug.com

Cell-Based Techniques

Bacteria Culture Cell-Based Assays Confocal Microscopy Eukaryotic Cell/Tissue Culture Flow Cytometry Fluorescence Microscopy Gene Expression Analysis High Content Screening High-Throughput Screening

(HTS) Immunohistochemistry Light Microscopy Stem Cell Culture/Analysis

19


gene2drug.com

Genomics Techniques

Classical End-Point PCR Cloning/Molecular biology

Techniques DNA/RNA Microarrays Genome Editing (e.g.

CRISPR/Cas9) (New) Genotyping Next Generation Sequencing Real-Time PCR RNAi (including siRNA, miRNA) Sanger DNA Sequencing Single Nucleotide Polymorphism

20


gene2drug.com

Protein Techniques

2-D Gel Electrophoresis Calorimetry (including ITC, DSC) Enzyme-linked Immunosorbent

Assay (ELISA) Label-Free Detection/Analysis

(Including Biosensors, SPR, etc.) Light Scattering (MALS, DLS) Mass Spectrometry Multiplex Bead Assays Protein Purification & Separation Protein Structural Analysis (NMR,

CD, etc.) Western Blotting

21


gene2drug.com 22

Sample Data from 2014 Outlook


gene2drug.com 23



gene2drug.com 24



gene2drug.com

Deliverable

Section 1

Overview and Regional Comparisons

Sections 2-4

Market Analysis and Funding Situations of US, Europe, and Asia, respectively

Section 5-6

Study Methodology and Demographics

Verbatim Comments from Survey Respondents

25


gene2drug.com 26

Why this report?


gene2drug.com

Share Gain/Share Protect Strategies

Where is the growth?

Funding trends?

Are researchers pitching their grants to follow the money?

27


gene2drug.com

How You Can Use It

Check assumptions

Make decisions

Forecast revenues

Identify potential growth

28


gene2drug.com

Benefits of Being a Sponsor

29

ObjectivityStart-up Time

Pre-fielding Input

Expertise

Efficiency

Cost Control


gene2drug.com

Pricing

30

As a standalone project, a report of this scope would cost:

$90,000-$100,000


gene2drug.com

Pricing

31

As a multi-sponsor report, the cost of sponsorship is only

$15,000

Deliverables include:• Electronic PDF Report• Data Set in XLS Format• Data Legend

Deadline: July 15, 2015Cost of non-sponsorship access is

$18,000


gene2drug.com 32

Questions?


gene2drug.com

Contact

Robin Rothrock, Ph.D.Director of Publications703.778.3080 [email protected]

33

Zach FrenchMarketing & Sales Manager703.778.3080 [email protected]

2016 Life Science Global Funding & Lab Budget Outlook

July 2015

2016 Global Life Science Funding & Lab Budget Outlook

Data & Analytics

Transcript of 2016 Global Life Science Funding & Lab Budget Outlook